HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

ABDEL-FATAH, T. M. A ; MCARDLE, S. E. B ; JOHNSON, C ; MOSELEY, P. M ; BALL, G. R ; POCKLEY, A. G ; ELLIS, I. O ; REES, R. C ; CHAN, S. Y. T

British journal of cancer, 2014-05, Vol.110 (10), p.2450-2461 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível